ARHGEF7 and focal segmental glomerulosclerosis: Arhgef7 is an important activator of Cdc42, and podocyte-specific Arhgef7 knockout mice exhibited progressive proteinuria and FSGS with reduced Cdc42 activity (Table 2) [49].